Reversal of LTP-Like Cortical Plasticity in Alzheimer’s Disease Patients with Tau-Related Faster Clinical Progression
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reversal of LTP-Like Cortical Plasticity in Alzheimer’s Disease Patients with Tau-Related Faster Clinical Progression
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 50, Issue 2, Pages 605-616
Publisher
IOS Press
Online
2016-01-22
DOI
10.3233/jad-150813
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cognitive reserve and the risk for Alzheimer's disease: a longitudinal study
- (2015) Laura Serra et al. NEUROBIOLOGY OF AGING
- Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease
- (2015) Rodrigo P. Almeida et al. JAMA Neurology
- New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
- (2014) Miguel Medina et al. BIOCHEMICAL PHARMACOLOGY
- Compensatory mechanisms in higher-educated subjects with Alzheimer’s disease: a study of 20 years of cognitive decline
- (2014) Hélène Amieva et al. BRAIN
- Inter-individual Variability in Response to Non-invasive Brain Stimulation Paradigms
- (2014) Virginia López-Alonso et al. Brain Stimulation
- Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
- (2014) Shichun Tu et al. Molecular Neurodegeneration
- Dopaminergic Modulation of Cortical Plasticity in Alzheimer’s Disease Patients
- (2014) Giacomo Koch et al. NEUROPSYCHOPHARMACOLOGY
- “Is dopamine involved in Alzheimer's disease?â€
- (2014) Alessandro Martorana et al. Frontiers in Aging Neuroscience
- CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease
- (2013) Simone Lista et al. Alzheimers & Dementia
- Frailty Among Alzheimer’s Disease Patients
- (2013) Giacomo Koch et al. CNS & Neurological Disorders-Drug Targets
- Paired Associative Stimulation Enforces the Communication between Interconnected Areas
- (2013) D. Veniero et al. JOURNAL OF NEUROSCIENCE
- Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease
- (2013) Taher Darreh-Shori et al. NEUROBIOLOGY OF AGING
- A role for tau at the synapse in Alzheimer's disease pathogenesis
- (2013) Amy M. Pooler et al. NEUROPHARMACOLOGY
- Differential Pharmacological Effects on Brain Reactivity and Plasticity in Alzheimer’s Disease
- (2013) Anna-Katharine Brem et al. Frontiers in Psychiatry
- The Synaptic Accumulation of Hyperphosphorylated Tau Oligomers in Alzheimer Disease Is Associated With Dysfunction of the Ubiquitin-Proteasome System
- (2012) Hwan-Ching Tai et al. AMERICAN JOURNAL OF PATHOLOGY
- The Role of Interneuron Networks in Driving Human Motor Cortical Plasticity
- (2012) M. Hamada et al. CEREBRAL CORTEX
- Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer’s disease patients
- (2012) Alessandro Martorana et al. JOURNAL OF NEURAL TRANSMISSION
- Deciphering the mechanism underlying late-onset Alzheimer disease
- (2012) Dimitrije Krstic et al. Nature Reviews Neurology
- Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients
- (2012) Alessandro Martorana et al. NEUROPHARMACOLOGY
- Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau
- (2012) Cristian A. Lasagna-Reeves et al. Scientific Reports
- Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau
- (2011) Alessia Usardi et al. FEBS Journal
- Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
- (2011) Cristian A Lasagna-Reeves et al. Molecular Neurodegeneration
- Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
- (2010) Jorge J Palop et al. NATURE NEUROSCIENCE
- CSF biomarkers predict a more malignant outcome in Alzheimer disease
- (2010) A. K. Wallin et al. NEUROLOGY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CSF biomarkers in relationship to cognitive profiles in Alzheimer disease
- (2009) A. E. van der Vlies et al. NEUROLOGY
- Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake
- (2009) Shaomin Li et al. NEURON
- Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients
- (2009) Alessandro Martorana et al. NEUROPSYCHOPHARMACOLOGY
- Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases
- (2008) C. Hugh Reynolds et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization
- (2008) I. Klyubin et al. JOURNAL OF NEUROSCIENCE
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
- (2007) Miroslaw Brys et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now